JLB & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
JLB & Associates's MDT Position: Q3 2017 in Review
JLB & Associates sold out of Medtronic (MDT) in Q3 2017, closing a stake of 17,392 shares — an estimated $1.54M sold.
JLB & Associates first reported a position in MDT in Q2 2013 and held it in 16 quarters. The position peaked at $2.06M in Q2 2016. 1,291 funds tracked by Wall St. Rank hold MDT as of Q3 2017.
- JLB & Associates reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
- JLB & Associates sold 17,392 Medtronic shares in Q3 2017, an estimated $1.54M.
- JLB & Associates first reported a position in Medtronic in Q2 2013 and held it in 16 quarters.
- JLB & Associates's Medtronic position peaked at $2.06M in Q2 2016.
- 1,291 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.
Based on JLB & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.